As of 30 June 2026, 7 Indian mutual funds hold Rossari Biotech Limited (Materials), led by Motilal Oswal Small Cap Fund at 0.57% of its net assets, per the AMCs' SEBI-mandated monthly disclosures.
As of 30 June 2026, 7 Indian mutual fund schemes disclose a holding in Rossari Biotech Limited (Materials). The table below lists every fund holding this stock along with its weight as a percentage of the fund's net assets (% to NAV), sorted from the highest conviction position downward.
Across the 7 funds holding Rossari Biotech Limited, the average position size is 0.41% of net assets. The highest-conviction holder is Motilal Oswal Small Cap Fund (Equity), at 0.57%. Equity funds account for 6 of the 7 holders, with the rest spread across 1 other category. Over the last month, 0 funds initiated a new position and 1 fund exited.
How funds changed their Rossari Biotech Limited position between their two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| # | Fund | AMC | Category | % to NAV |
|---|---|---|---|---|
| 1 | Motilal Oswal Small Cap Fund | Motilal Oswal Mutual Fund | Equity | 0.57% |
| 2 | UTI Small Cap Fund | UTI Mutual Fund | Equity | 0.57% |
| 3 | UTI Multi Cap Fund | UTI Mutual Fund | Equity | 0.47% |
| 4 | CANARA ROBECO SMALL CAP FUND | Canara Robeco Mutual Fund | Equity | 0.36% |
| 5 | UTI - Flexi Cap Fund | UTI Mutual Fund | Equity | 0.36% |
| 6 | UTI Large & Mid Cap Fund | UTI Mutual Fund | Equity | 0.3% |
| 7 | UTI Aggressive Hybrid Fund | UTI Mutual Fund | Hybrid | 0.27% |
Want to interpret these weights? Read How to Read a Mutual Fund's Monthly Portfolio Disclosure, or look up terms like % to NAV and conviction in the glossary.
Source: SEBI-mandated monthly portfolio disclosures by Indian AMCs. Percentages are of each fund's net assets on its latest disclosure date. For information only, not investment advice.